Navigation Links
Appeal of Lawsuit by Former Chief Executive Officer- Reinstated; and Sanctions Order Vacated
Date:3/22/2010

PHILADELPHIA, March 22 /PRNewswire/ -- The Superior Court of Pennsylvania has reinstated an appeal filed by John R. DePhillipo, former Chief Executive Officer of GeneLink Biosciences, and his wife Maria. The appeal had been dismissed by an order from the same court on February 18, 2010. The Superior Court also ordered "The Prothonotary to list the matter for argument before the first available panel."

Originally, DePhillipo and his wife filed suit against GeneLink and GeneWize, a wholly owned Subsidiary of GeneLink, claiming they were induced to settle an Atlantic County, N.J. law suit by fraud. The complaint alleged that GeneLink's attorney made false representations to John DePhillipo, his lawyer and the trial judge relative to the alleged poor economic well being of GeneLink. ("Defendant GeneLink, Inc. was in such dire financial straits that he didn't know how they were able to pay his attorneys fees.")

Within an hour after the DePhillipos settled the Atlantic County case, GeneLink officers filed a press release revealing, for the first time, the existence of their wholly owned subsidiary, GeneWize. They also added that GeneWize had sold approximately 250 presidential founder memberships for One Thousand ($1000.00) dollars and over 4,000 GeneWize dealerships for Five Hundred ($500.00)

The Common Pleas Court Philadelphia judge dismissed the case ruling that GeneLink's lawyer was only puffing. The appeal to the Superior Court followed.

SOURCE GUSTINE J. PELAGATTI & ASSOCIATES

Back to top
'/>"/>
SOURCE GUSTINE J. PELAGATTI & ASSOCIATES
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Appeal of Lawsuit by Former Officer Dismissed; Request for Sanctions Granted
2. Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years
3. deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal
4. Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group
5. Federal Circuit Rules in Marteks Favor in Appeal of Patent Infringement Case
6. Court of Appeals Overturns 2005 Patent Verdict Against Cordis
7. Ortho-McNeil Neurologics to Appeal Patent Ruling on RAZADYNE(R)
8. WorldHeart Announces Delisting Appeal Received and Will be Considered at Hearing July 10, 2008
9. Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts
10. Insmed to Appeal Delisting Notification From Nasdaq
11. Genta Completes Appeal of FDA Decision for Genasense(R) in CLL
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... ... December 01, 2016 , ... ACEA Biosciences, Inc. announced today that it will ... AC0010 at the World Conference on Lung Cancer 2016, taking place in Vienna, Austria ... I/II clinical trials for AC0010 in patients with advanced non-small cell lung cancer harboring ...
(Date:12/2/2016)... ... December 01, 2016 , ... Aerocom Healthcare ( ... hospitals, will present its chain-of-custody solution for tracking and securing medications at booth ... Dec. 4-8, 2016. , Aerocom has a proven solution for tracking medications via ...
(Date:12/2/2016)... ... 2016 , ... The Conference Forum has announced that the 3rd annual ... on February 1-3, 2017 at the Roosevelt Hotel in New York City. Led by ... unique 360-degree approach, which addresses the most up-to-date information regarding business aspects, clinical advancements ...
(Date:12/2/2016)... ... December 01, 2016 , ... Orthogonal, ... on their recent FDA Class II 510(k) clearance for their flagship medical device, ... commercializing remote cardiac monitoring devices that rely on cloth-based nanosensors. While other companies ...
Breaking Biology Technology:
(Date:11/17/2016)... 2016 Global Market Watch: Primarily supported ... Population-Based Banks and Academics) market is to witness a value ... shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% ... the analysis period 2014-2020. North America ... by Europe at 9.56% respectively. ...
(Date:11/15/2016)... Nov. 15, 2016  Synthetic Biologics, Inc. (NYSE ... focused on the gut microbiome, today announced the ... shares of its common stock and warrants to ... a price to the public of $1.00 per ... Biologics from the offering, excluding the proceeds, if ...
(Date:11/14/2016)... , Nov. 14, 2016  Based ... identification market, Frost & Sullivan recognizes FST ... Sullivan Award for Visionary Innovation Leadership. FST ... the biometric identification market by pioneering In ... solution for instant, seamless, and non-invasive verification. ...
Breaking Biology News(10 mins):